Self‐Reported Dysphagia in Head and Neck Cancer Survivors From Diagnosis to Twelve Months Post Treatment and Predictors for Moderate to Severe Long‐Term Dysphagia
Head & Neck · 2026-11-09
DOI: 10.1002/hed.70541 ↗Abstract
ABSTRACT Background Dysphagia is a common complication of head and neck cancer (HNC) and its treatment. This study examined swallowing‐related quality of life from diagnosis to 12 months after treatment, compared swallowing outcomes across tumor sites and treatment modalities, and identified predictors of moderate‐to‐severe dysphagia. Methods The M. D. Anderson Dysphagia Inventory (MDADI) was completed by 445 patients receiving curatively intended HNC treatment pre‐treatment and at 3‐, 6‐, and 12‐months post‐treatment. Results Swallowing‐related quality of life worsened during treatment, the poorest scores at 3 months post‐treatment; 21.6% reported moderate‐to‐severe dysphagia, decreasing to 12.5% at 12 months. Risk factors for dysphagia at 12 months included stage IV disease, surgery combined with (chemo)radiotherapy, smoking cessation within 12 months, and pre‐treatment sick leave. Patients with cervical carcinoma of unknown primary (CCUP) had the poorest outcomes. Conclusions Swallowing function declined during treatment. Patients receiving surgery combined with (chemo)radiotherapy and patients with CCUP are at increased risk of long‐term dysphagia and require closer follow‐up.
EUVIMED